The compound provides non-opioid pain relief by targeting neurotensin receptor 1 (NTSR1) on sensory neurons and within the ...

Six months into the year, health officials say the steep reversal in opioid overdose deaths is cause for celebration. But ...

Drug overdose is the number one cause of accidental death in Connecticut, where someone is more likely to die from a drug ...

Stemming the tide of opioid addiction in Central Illinois takes that person-to-person connection, a realization that ...

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...

In 2024, there were 169 opioid overdose deaths in Boston — a 38% drop from the prior year, in line with the national trend.

New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that blocks kappa ...

Researchers from the University of Missouri School of Medicine have shed light on what populations are more likely to be ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Indiana Governor Braun signed a law easing restrictions on opioid prescriptions for chronic pain patients with implantable ...